Sam's News — health — 2026-08-21¶
Health¶
8 Merck and Moderna's personalized melanoma vaccine extends cancer-free survival in phase three trial¶
A new personalized mRNA-based vaccine (Intismeran) combined with the immunotherapy drug Keytruda has shown promising results in stopping skin cancer recurrence in patients with high-risk melanoma. The phase three trial of over 1,000 patients demonstrated the combination significantly extended cancer-free survival and reduced disease spread compared to Keytruda alone.
- Phase three trial involved 1,000+ patients with high-risk stage 2–4 melanoma
- Vaccine created using mRNA technology targeting individual patient tumor mutations
- Combination with Keytruda significantly extended cancer-free survival and reduced metastatic spread
- Treatment still requires peer review, regulatory approval, and NHS evaluation before availability
Sources: BBC News AI Web Searched
7.5 Six 30-second sprints produce greater metabolic changes than 90 minutes of cycling¶
Rockefeller University researchers found that six 30-second all-out sprints altered nearly one-quarter of measured blood proteins and over 200 metabolites, far exceeding metabolic changes from 90 minutes of moderate cycling. Many sprint-responsive proteins were linked to lower cardiovascular and metabolic disease risk, with over one-quarter associated with slower biological aging.
- Six 30-second sprints altered ~25% of measured blood proteins
- Moderate cycling altered <0.25% of proteins measured
- Sprints triggered 200+ metabolite changes
- 32 of 33 disease-protective proteins altered by sprinting; only 3 by cycling
- >25% of protective proteins linked to slower biological aging
- Response persisted after 8 weeks of training
- Six 30-second sprints altered ~25% of blood proteins vs. <0.25% for 90-minute moderate cycling
- Over 200 metabolites changed immediately after sprinting
- 32 of 33 disease-protective proteins were altered by sprinting; only 3 by moderate exercise
- More than one-quarter of protective proteins linked to slower biological aging
- Response persisted after eight weeks of training
Sources: ScienceDaily AI Web Searched, ScienceDaily — Health RSS
7.5 At-home colorectal cancer screening reduces mortality risk by 43% in long-term Swedish study¶
A 14-year Swedish study of 376,000 participants found that completing at-home colorectal cancer screening reduced mortality risk from the disease by 43%. The screening program offered stool-based tests every two years to detect blood, with positive results triggering further testing.
- Study tracked 376,511 participants up to 14 years
- 43% mortality risk reduction from completing screening
- 1,668 colorectal cancer deaths recorded
- Screening offered every two years to ages 60-74
- Published in JAMA Network Open by Karolinska Institutet and Umeå University
Sources: ScienceDaily AI Web Searched, ScienceDaily — Health RSS
7 GDF15 hormone protects liver from inflammation without weight loss¶
McMaster University researchers found that GDF15, an appetite-suppressing hormone, protects the liver from inflammation and scarring through a brain-to-liver pathway independent of weight loss. The hormone activates nervous system signaling that triggers glucocorticoid release, suppressing liver inflammation and slowing fibrosis progression.
- GDF15 activates brain-to-liver signaling pathway
- Liver protection occurs independently of weight reduction or food consumption
- Glucocorticoids suppress inflammation and slow fibrosis progression
- Published in Cell Metabolism, August 10, 2026
- Study used mouse models of metabolic dysfunction-associated steatohepatitis (MASH)
- GDF15 activates brain-to-liver pathway via glucocorticoid release to suppress liver inflammation
- Protective effects observed regardless of weight loss, food consumption changes, or liver fat reduction
- Study published in Cell Metabolism on August 10, 2026
- GDF15 also slowed progression of liver fibrosis (scar tissue accumulation)
- Implications for treating MASH, which can lead to cirrhosis, liver cancer, and liver failure
Sources: ScienceDaily AI Web Searched, ScienceDaily — Health RSS
7 Gut bacteria compound butyrate trains intestine to fight inflammation¶
Northwestern Medicine researchers discovered that butyrate, a short-chain fatty acid produced by gut bacteria fermenting dietary fiber, reprograms intestinal cells to maintain long-term anti-inflammatory protection. Two weeks after treatment withdrawal, mice showed sustained elevated IL-10 levels and greater resistance to colitis.
- Butyrate induces sustained IL-10 production in CD4+ T-cells
- Protective effect persisted 2 weeks after treatment withdrawal
- Protection dependent on IL-10 signaling, not microbiome changes
- Effect observed in germ-free mice lacking microbes
- Published in Nature Communications
Sources: ScienceDaily AI Web Searched, ScienceDaily — Health RSS
6.5 Focal Therapy for Prostate Cancer Remains Divisive Among Physicians¶
Urologic oncologists remain split over whether focal therapy offers advantages compared to traditional prostate cancer treatments like surgery or radiation, pending new data.
Sources: STAT News RSS
6.5 AI predicts vaccine response strength before immunization¶
Researchers used AI to analyze antibody patterns and identify signs of immune readiness that predict how strongly someone will respond to a vaccine.
Sources: ScienceDaily — Health RSS
6.5 Merck Ebola vaccine deployed in Democratic Republic of Congo¶
Scientists deploy Merck's Ebola vaccine in the Democratic Republic of Congo as part of public health response efforts.
Sources: STAT News RSS
Health Policy¶
7 HHS documents outline vaccine policy recommendations under new administration¶
The president of the United States and Health Secretary Robert F. Kennedy Jr. opened a 30-day public comment period requesting feedback on vaccine policy changes, including whether new recommendation categories should be added to the current framework. CDC Director Erica Schwartz affirmed that vaccines are safe and effective.
- 30-day public comment period initiated on Friday
- Seeks feedback on adding new vaccine recommendation categories
- Current framework: universal, risk-based, and shared clinical decision-making recommendations
- CDC Director Erica Schwartz affirmed vaccine safety and effectiveness
Sources: STAT AI Web Searched, STAT News RSS
Pharma¶
6.5 Roche's Genentech invests $750 million in Oregon production facility expansion¶
Roche's Genentech will invest $750 million to double the size of its existing production facility in Oregon.
Sources: STAT News RSS